Article Public (all visitors)

Pharmaceuticals and innovation. Less buck for the bang. Are drug patents worth it?

The Economist 2021

Politicians are attacking IP protection, but shareholders are Big Pharma’s bigger headache | Business

View Original Source

Curated by

FoundryBase

Updated 9 days ago

COPYRIGHT   HEALTHCARE   INNOVATION   LEGAL   MEDICINE   PHARMACEUTICAL INDUSTRY   POLICY   UNITED STATES, USA  

Save

Bookmark this resource

Browse more

View all Articles

Continue from source

More from source

Browse more from The Economist

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.

Log in to suggest Create account